Our client Abac Therapeutics raises $16M
ABAC Therapeutics Announces €16 Million Series A to develop therapeutic solutions to fight antibiotic-resistant bacteria BARCELONA, Spain – February 15th, 2018 — ABAC Therapeutics (ABAC), a leader in pathogen-specific antibiotics, announced today the closing of a €16 million Series A round. The financing was led by Pontifax with participation from the Global Health Science […]
Our client Eloxx Pharmaceuticals Secures US$8 Million Investment from LSP
Eloxx Pharmaceuticals Secures US$8 Million Investment from LSP, Increasing Total Raised in Series C to US$38 million August 2, 2017 Financing to support advancement of novel disease-modifying therapy targeting genetic diseases, including cystic fibrosis SAN DIEGO and REHOVOT, Israel, Aug. 2, 2017 /PRNewswire/ — Sevion Therapeutics, Inc. (OTCQB: SVON) and Eloxx Pharmaceuticals Ltd., a clinical stage company developing […]
